chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid-19 Positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 Positive) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced COVID-19 (Covid-19 Positive). On 17-Feb-2021, COVID-19 (Covid-19 Positive) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter. Treatment includes Treatment for COVID-19 disease.
smoked cigarettes for nearly 30 years and the day after the vaccine she lost the mental aspect of craving them; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EN5318), via an unspecified route of administration into right arm on 22Jan2021 19:45 (at the age of 49-year-old) at a single dose for COVID-19 immunisation. Medical history included ongoing cigarette smoker and smoked cigarettes for nearly 30 years. Patient was not pregnant. Concomitant medication included calcium (VIACTIV), evening primrose oil [oenothera biennis oil] (EVENING PRIMROSE OIL [OENOTHERA BIENNIS OIL]), linum usitatissimum seed (FLAXSEED) and multivitamin. The patient previously took demerol and codeine and experienced drug allergy to both drugs. It was reported that the patient has smoked cigarettes for nearly 30 years and the day after the vaccine (also reported as 30Jan2021 07:00), she lost the mental aspect of craving them. She have gone from a pack a day to four or five because her body still craves them. The event was reported as non-serious. The patient has not received treatment from the event reported. Outcome of event was not recovered.
4/26/23 I had a dry, nonproductive cough and it would not stop. I also had a lot of wheezing. I went into coughing episodes. On 4/30/23, I went to the urgent care. I was diagnosed with bronchitis. I had a chest x-ray which they did not see pneumonia. I was prescribed AUGMENTIN and steroids. I began taking the medications that night. The symptoms continued. I had no fever. I developed a horrible postnasal drip which made the cough much worse. I went to my primary doctor who prescribed albuterol nebulizer. Gradually, the symptoms abated.
After both Moderna  boosters I have had very bad reactions. I forgot that the first one made me feel like heck - I would?ve have gotten the second booster.  I have migraine , fever, chills, lethargy. This started about 2 days after the vaccine. And I?m 8 days out right now.  Its like having the flu.  Without the cold symptoms. I have a little bit of nasal congestion - but not sure if that?s seasonal allergies. I was so sick after the first booster, my doctor had me checked for Cytomeglovirus. It was negative. I believe that it lasted 2 months after the first booster. I am hoping there?s something I can take for relief after this second booster. I have stuff to do. And this is debilitating-  the headache and fatigue.
Tongue swelling, difficulty swallowing. 25mg Benadryl given IM at 10:35 AM.
after vaccination  site bled so a cotton ball was held to the site.  after removal of the cotton ball I noticed the site was visible swollen about the size of  a penny.  within 1 minute the site had swelled to the size of a half dollar.   pt reported no trouble breathing and no pain at site.  site was not red but swollen.  instructed pt wife who was with him to drive him top the nearest urgent care for evaluation.
redness, rash, hot to touch and pain at injection site; redness, rash, hot to touch and pain at injection site; redness, rash, hot to touch and pain at injection site; redness, rash, hot to touch and pain at injection site; This is a spontaneous report from a contactable pharmacist. A 67-year-old female patient started to receive pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13; NDC number: 0005197102, lot number: X39679 and expiration date: 30Oct2020), intramuscular on 04Apr2019 at 17:40 at 0.5 ml, single on the left arm at the pharmacy/drug store for vaccination. Medical history included high blood pressure. Concomitant medication included unspecified high blood pressure medication. The patient experienced redness, rash, hot to touch and pain at injection site in Apr2019. Outcome of the events was not recovered. Events were assessed as non-serious and related to suspect drug.
12 hours after vaccine I had a fever reaching 101 degrees F, chills, body aches, fatigue, and severe headache lasting for 24 hours.
NauseaVomiting, HYPERtension, Tachycardia, chills Narrative:
mom brought child in clinic on 5-11-05 for nurse to look at spots on child. noticed them the night before after bath. noticed more the next morning and called the clinic and was told to bring him in.
arm was sore; temperature of 99 degrees for 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore) and PYREXIA (temperature of 99 degrees for 4 hours) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LIDOCAINE, PRILOCAINE (EMLA [LIDOCAINE;PRILOCAINE]) for Pain.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was sore) and PYREXIA (temperature of 99 degrees for 4 hours). At the time of the report, VACCINATION SITE PAIN (arm was sore) and PYREXIA (temperature of 99 degrees for 4 hours) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Body temperature: 99 99 degrees.         Treatment included use of ice to treat sore arm.   This case was linked to MOD-2021-109769 (Patient Link).
Severe chills (shivering hard for over 2 hours); fever; long-lasting headache; muscle pain throughout the body
Patient complained of feeling disoriented and sick to her stomach. Pain worsens if patient moves around. Patient has received water from vaccinator. Patient recovered and was released at 2:45 pm. At 2:26pm, the heart rate was at 79 bpm and the blood pressure was at 143/85. The oxygen saturation and respirations were normal. At 2:36pm, the heart rate was at 72 bpm and the blood pressure was at 135/84. The oxygen saturation and respirations were normal. At 2:43pm, patient had normal respirations and oxygen saturation. Heart rate was at 77 bpm and blood pressure was at 126/72.
pt recv vax;may94 HIV pos pt spit bloody saliva in pt's eye;lab tests showed incident was neg for anti-HBs & pos for HBsAg & anti-HBc;
Starting on 1/22/21 her arm started to itch, got red circle around injection site about a quarter size, warm and hard in that area.  On 1/23/21, started to put warm compresses x 3, Sunday the same thing and by Monday it had dissipated and was fine.  Then last night 1/29/21, about 1:30 AM got up as she was not sleeping well, took two Aleve.  Woke up this morning with arm itching, red again and kind of warm.  Feels fine but that location has reappeared from the initial injection.  Pink in color and warm to touch.
Janssen COVID-19 Vaccine EUA: patient presented to outside facility one day after vaccination reporting confusion, vomiting,and abdominal pain. Found to be hypotensive (blood pressure 70/40 mmHg) in DKA with electrolyte abnormalities and ventricular arrhythmias requiring shocks. Patient initiated on blood pressure support, airway protection, insulin, intravenous fluids, antimicrobials, electrolyte management and transferred to this facility for a higher level of care. Patient improved, DKA and shock resolved, electrolytes normalized, and was discharged five days later medically stable.
Severe, debilitating, constant nerve pain radiating from hands to above the elbows, face numb, tongue numb, entire body tingling, numbness, severe unrelenting pain which has yet to subside.
Initial information received on 17-Oct-2018 regarding an unsolicited valid non-serious case received from an other health professional. This case involves Adult female patient of unknown age who experienced redness at injection site, heat at injection site, swelling and slight rash, while she received vaccine FLUZONE QIV. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UJ034AB via unknown route. On an unknown date, the patient developed a non-serious redness at injection site following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date, the patient developed a non-serious heat at injection site following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date, the patient developed a non-serious swelling following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date, the patient developed a non-serious slight rash following the administration of INFLUENZA QUADRIVAL A-B VACCINE. (Other relevant tests included No lab data.) Final diagnosis was slight rash, swelling, and heat at injection site and redness at injection site. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for swelling, as Unknown for redness at injection site, as Unknown for slight rash and as Unknown for heat at injection site. List of documents held by sender: none.
She had a knee replacement surgery on 03Oct2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 67-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Sep2022 as dose 5 (booster), single (Lot number: GJ2524) at the age of 66 years for covid-19 immunisation. The patient's relevant medical history included: "Allergy to sulfa" (ongoing), notes: had to do with medication for knee replacement. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1, Batch/lot number: EP7533), administration date: 01Apr2021, when the patient was 65-year-old, for COVID-19 immunization; BNT162b2 (Dose: 2, Lot: EW0173), administration date: 29Apr2021, when the patient was 65-year-old, for COVID-19 immunization; BNT162b2 (Dose: 3, Lot: FF2593), administration date: 12Nov2021, when the patient was 66-year-old, for COVID-19 immunization; BNT162b2 (Dose: 4, Lot: Either FJ4489 or FJ4989), administration date: 12Apr2022, when the patient was 66-year-old, for COVID-19 immunization. The following information was reported: KNEE ARTHROPLASTY (hospitalization) with onset 03Oct2022, outcome "unknown", described as "She had a knee replacement surgery on 03Oct2022". The patient was hospitalized for knee arthroplasty (start date: 03Oct2022, discharge date: 05Oct2022, hospitalization duration: 3 day(s)). Therapeutic measures were taken as a result of knee arthroplasty. Clinical course included: The product was Comirnaty, Gray cap, Original/Omicron BA.4/BA.5 (Bivalent) She stated she had the Pfizer COVID vaccine in Apr2021 and never had a problem. Then Pfizer recommended that 5 months later it was recommended to get a booster so she had her boosters (all Pfizer) since 2021 and 2022. The last booster was 17Sep2022 (Lot# could be 6J2524 or GJ2524 but she thinks it is GJ2524 based on how they wrote other 6's on her card). She had a knee replacement surgery on 03Oct2022 and they were putting her in a nursing home after for 2 weeks because she had no help at home. Her doctor told them to stay home because this is a major surgery and she did exactly what he said. Patient was hospitalized for knee replacement surgery from 03Oct2022 to 05Oct2022 and sent to nursing home after hospital discharge for recovery, due to living situation.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300131331 same patient/drug, different dose number/event;
Sunday Jan 24- body aches and low grade fever Monday Jan 25- Rash on hands and feet, fever and diarrhea. Vomiting at night Tuesday Jan 26- fever,  diarrhea, tiredness Wednesday Jan 27- low grade fever and diarrhea and tiredness Thursday Jan 28- diarrhea and abdominal cramping Friday Jan 29- abdominal cramping and gas
I had a heavy premature menstrual bleeding following each Pfizer  dose. Since receiving the first dose my periods have been extremely heavy and lasting 7-10days. Before the vaccine my periods were 3 days long and not heavy.
Myalgia, Fever, Diarrhea, Injection site soreness Narrative:
Diffuse rash all over body including hands and face presenting day 12 following vaccine administration, started overnight and continued to get worse until day 3 . Rash is red, raised and closely spaced, does not seem itchy as child behavior is not scratching.
No tx currently. Right forearm is painful to touch/movement, blotchy by hand sx noticed 11/14/12 am, flu on admin 11/06/12 pm.
I got the 1st shot and 4 days later broke out in shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis and COVID-19 VACCINE for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine, the 2nd dose of COVID-19 VACCINE and the 1st dose of COVID-19 VACCINE. On an unknown date, 4 days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: Receipt Date: 7-May-2022 Reporter's Comments: : This case was reported by a consumer via interactive digital media. The case was reported by patient. The patient got the 1st shot and 4 days later the patient broke out in shingles. The doctor said not a result of just the Shingles shot, but rather a result of getting the Shingles shot so soon after having received the first 2 covid vaccinations. Additional Supportive Information: The follow up would not be possible since no contact details provided.
This infant had erythema 2 x 4 cm one day following immunization, Prevnar #2. At the time of Prevnar #1, she had the same reaction.
Caller is breastfeeding and received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Caller is breastfeeding and received the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The mother's past medical history included Maternal exposure during breast feeding.    No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (Caller is breastfeeding and received the vaccine). At the time of the report, EXPOSURE VIA BREAST MILK (Caller is breastfeeding and received the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
On 05/17/2001 during pre k school day child complained of some soreness to right arm to teacher. On 05/18/2001 child complained of more severe discomfort in right deltoid area. It was red and warm to touch. His temp was 100.4 at school nurse's office. Sent home with parent with instructions for comfort and care. Primary MD advised of local reaction to DTAP this dose.
This morning weak feel cold nausea. He may contact clinic - has not as of this writing (per wife - interpreter).
28 days after vaccine I was having coffee with a friend and felt a pinprick stinging sensation in my left hand in ring and middle fingers. Began having swelling, itchy, and burning in left hand. Went to dermatologist and he was baffled. Then went to the doctor and he tested me for arthritis, which was negative. He then recommended that I double my medication for my autoimmune disease and that cleared up the reaction after 12 weeks on increased dose.
Left deltoid tender to touch with redness and swelling, slightly warm to touch, can feel hard lump in area of injection.
Approximately 30 minutes after receiving the COVID-19 vaccine the patient was driving home and started to experience blurry vision in her left eye, dizziness, and felt flushed. The patient returned back to the vaccine clinic and was seen by EMS on scene. The patient did not complain of any shortness of breath, chest pain, nausea, or vomiting. She was no longer dizzy but was still having blurred vision in her left eye.  She stated that she was seeing black lines out of the periphery of her eye. The patients vitals were taken and are as follows: B/P 160/pal,  HR 85, %O2 99, BGL 106. The patient did not want to be transported to the hospital. The patient called her daughter to arrange a ride home and scheduled an appointment with her eye doctor and her primary care physician.  Outcome: The patient saw her eye doctor and was diagnosed with a partially detached retina in her left eye.
Case number PHEH2015US027552 is an initial spontaneous report received from a consumer (patient) on 31 Dec 2015. This report refers to a 64 year old female patient. Her medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly in Dec 2015. On 29 Dec 2015, 36 hours after vaccination, the patient experienced trigeminal neuralgia. The patient stated that she had severe gastrointestinal (GI) pain followed by facial pain radiating from the corner of the left eye. The events outcome was not reported, however stop date of the event was reported as 29 Dec 2015. The seriousness of the event was not reported, but the event trigeminal neuralgia was upgraded as medically significant based on the information available in the source documents. The causality of the events was not reported. The reporter denied consent to contact for further follow ups and hence the case was considered as lost to follow up.
Patient had fever and two seizure like events within 4 hours of the shots. Went to local emergency room, and was cleared without testing.
ON 5-16-06 THIS CHILD RECEIVED HER 5 YR VACCINES. ON 5-18-06 THE CHILD RETURNED TO OUR OFFICE WITH LOCAL ALLERGIC REACTION TO THE LEFT THIGH IN WHICH THE DTAP WAS GIVEN.  THE LEFT THIGH HAD GENERALIZED REDNESS, NON-TENDER, NON-FLUCTUANT, SLIGHT WARMTH TO AREA.  SHE WAS GIVEN ZYRTEC, APPLY A COOL COMPRESS TO AREA, AND ADVISED TO CALL IF WORSENS.
This spontaneous report as received from a pharmacist refers to unspecified number patients of unknown age and gender. The patients' pertinent medical history, drug reactions and allergies were not reported. On an unknown date the patients were vaccinated with ZOSTAVAX (dose, route, lot number and expiry date were not reported). On an unknown date the patients experienced rash. The pharmacist found this information in an unspecified media report and in an unspecified lecture. Full patient demographics could not be provided. It was not specified how many patients developed the rash. The outcome of rash was unknown. The causality was not reported. There was no product quality complaint involved. Additional information has been requested.
Patient is fully vaccinated for Covid and later was hospitalized and died.  Case son suspects case may have gotten it during a hospital visit July 30th after collapsing and hitting his head. Only close contact was case's son and wife, but he did not want to be contacted by contact tracers, almost through with quarantine.
I experienced a runny nose with mucus, blood running from nose with blood clots four to five times a day from March 8th 2021 up to March 10th  2021. It is unknown rather I have blood clots within my body.
Infanrix was accidentally administered instead of a dose of Boostrix; 12 year old received Infanrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 12-year-old patient who received DTPa (Infanrix) for prophylaxis.   On an unknown date, the patient received Infanrix. On an unknown date, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: Infanrix was accidentally administered instead of a dose of Boostrix) and inappropriate age at vaccine administration (Verbatim: 12 year old received Infanrix).  The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14-SEP-2023 A pharmacist called in to request information about the recommendations available for instances where a dose of Infanrix was accidentally administered instead of a dose of Boostrix in a 12 year old patient which led to Inappropriate age at vaccine administration and Wrong vaccine administered They had very limited information about the event, vaccine and patient but consented to receive follow up via e mail. The vaccine administration facility is the same as primary reporter. The reporter consented to follow up.
Experienced superficial thromophlebitis (blood clot) in left leg 21 days after vaccination. Note that I have varicose veins in that let and previously experienced the same condition at a different spot on the same leg 4 years earlier.
I was itchy and developed redness in my face and chest the night that I got the first dose of the vaccine. I did not go to the doctor and they went away in a day or so. I developed a fever and chills. I also had a headache. Those symptoms lasted for a night. The next day I was so fatigued, I could not even get up. I developed nauseous and vomiting the next day.
About 27 hrs after the vaccine, both forearms and hands were very itchy and had bumps. Within a few hours, there were hives and welts all over my body from head to toe. The pharmacist suggested taking benadryl orally and applying it to my skin. I showered and then felt dangerously weak to the point where I could not get dressed and qalk to my bed without grabbing onto walls. I took benadryl and applied it around 9pm and again at 3am. It did not improve.   It got worse. Today, I showered 2 times which gave temporary relief and continued with the benadryl.  I wasted the entire day in bed, feeling itchy and miserable. I had an appointment that I had to cancel because I was in no condition to put clothes on and see anyone. I have red bumps and rashes on my face and my entire body. I have never experienced anything like this before.   FYI- I had the Pfizer monovalent booster on Feb 25, 2022 and about 10 days later, I could not walk. I had intense abdominal pain. After ruling out things, I thought it may be gynecologist, so I rushed to see my Dr and was told all my lady parts were find and that it was a result of the booster as it is messing with our cycles.